Sign in
Not yet recruitingNo phase

Ultrashort Echo Time (UTE) MRI for Applicator Reconstruction in Gynaecologic Cancer Brachytherapy

Key facts

Who runs it
Mahidol University
Where
Thailand1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
50 people, planned
Starts
Dec 2026
Expected to end
Dec 2029
Type of study
Interventional
Treatments tested
  • Ultrashort Echo Time (UTE) MRI
Record updated
16 November 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Gynaecologic malignancy (cervix/endometrium/vagina) requiring BT with intracavitary or hybrid IC/IS applicator
  • Locally advanced cervical, endometrial, or vaginal cancer undergoing MRI-guided BT
  • Age ≥ 18 years
  • ECOG 0-2
  • Written informed consent

Who cannot take part

  • MRI contraindication (incompatible implant, severe claustrophobia)
  • non-MRI-compatible applicator required
  • inability to tolerate ~8 mins additional scan time

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex
  • Cervical cancer or endometrium cancer or vagina cancer

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical study is to learn whether an ultrashort echo time (UTE) MRI scan can show the position of brachytherapy applicators and needles more accurately than standard MRI scans in adults with gynaecologic cancer (cervical, endometrial, or vaginal cancer) who are receiving MRI-guided internal radiotherapy (brachytherapy).

Read full original descriptionShow less

The main questions it aims to answer are:

* Does UTE MRI locate the applicator and needle tips more accurately than standard T2-weighted (T2W) and proton-density-weighted (PDW) MRI, when compared with CT? * Does UTE MRI show a clearer contrast between the applicator and the surrounding tissue?

Researchers will compare applicator positions reconstructed from UTE, T2W, and PDW MRI with CT taken on the same day as the reference standard. They will also check whether differences in applicator reconstruction change the planned radiation dose, and whether image features (radiomics) from UTE MRI before treatment and before brachytherapy help predict cancer recurrence.

Participants will:

* Receive their usual standard brachytherapy treatment, which is not changed by this study * Have one additional MRI sequence (UTE, about 8 minutes) added to their standard MRI and CT scans at each brachytherapy planning session, with the applicator in place * Have an additional UTE sequence added to their routine MRI before treatment and before brachytherapy * Be followed during routine clinical visits for disease outcomes

The group in the trial

  • UTE MRITreatment being tested

    Gynaecologic malignancy (cervix/endometrium/vagina) requiring BT with intracavitary or hybrid IC/IS applicator. At every planning/fraction session: T2W, PDW, 3D UTE (1.5 mm isotropic) and same day CT (reference), all with applicator in situ on a Philips 1.5T system. An additional UTE sequence will be acquired alongside the standard T2W and DWI sequences at pre-treatment and pre-brachytherapy time points.

    Treatment: Ultrashort Echo Time (UTE) MRI

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07940361, who can take part
Record updated
16 November 2026